Imagine being able to get into the gym to train a body part more frequently than your competition can. Original post: December 19, 2017 (Franco Cavaleri PhDc Mr IFBB North America 1992) Imagine being able to get into the gym to train a body part more frequently than your competition can. What does that mean to you in six months of steady training? Imagine recovering faster from a stage-to-stage or day-to-day workload in your competitive sport such as a cycling tour; a triathl

Cellular protection from the outside-in; and the inside-out. Original post: December 15, 2017 Curcumin BDM30™ is a research-supported, patented technology delivering an exceptionally high concentration – 30% – of bisdemethoxycurcumin (BDMC). It is designed to help manage inflammation, joint pain and discomfort, and support recovery from day-to-day workouts or injuries. Over and above the new standard of anti-inflammatory activity this recent discovery presents a dual phase an

Curcumin III shoots the ORAC value of Curcumin BDM30™ through the roof. Part 1 of 2 Original post: December 11, 2017 Curcumin III (Bisdemeoxycurcumin –BDM) delivers an ORAC (Oxygen Radical Absorbance Capacity) value that outperforms any compound we’ve studied in the past. It is in the order of 6,245,000 UNITS. As a comparable example, to gain perspective, regular curcumin exhibits an ORAC value of only 9,500 UNITS when measured in precisely the same manner. This activity play

In relation to the novel anti-inflammatory mechanism; executed and discovered at Biologic Pharmamedical Research. Original post: December 2, 2017 This seminar was delivered at the Arnold Summit presenting research on the bisdemethoxycurcumin discovery by Franco Cavaleri in relation to the novel anti-inflammatory mechanism; executed and discovered at Biologic Pharmamedical Research (www.biologicpharmamedical.com). 25 minutes on KETOBA pharmacology in relation to NRf2 activatio